“My company maintained the safety information for MiddleBrook Pharma. I've known Brenda since 2006 and found her to be very knowledgeable of regulatory affairs, analysis of similar events, trend and signal detection and extremely thorough in her review of ICSRs to be submitted. She was always congenial and very pleasant to work with. I was amazed at how expediently she answered communications. She is a dedicated professional, excellent at management and multi-tasking. Even though my company was working for her, I felt that I was working with her. She would be a great asset to any company.”
Ijamsville, Maryland, United States
Contact Info
772 followers
500+ connections
Ijamsville, Maryland, United States
Contact Info
772 followers
500+ connections
Activity
-
Cellectar Biosciences and City of Hope Cancer Center (City of Hope) Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides…
Cellectar Biosciences and City of Hope Cancer Center (City of Hope) Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides…
Liked by Brenda Wolling
-
NOW ENROLLING: A phase 1a/1b study of an investigational FRα-targeting antibody drug conjugate (#ADC) in select solid tumors including ovarian…
NOW ENROLLING: A phase 1a/1b study of an investigational FRα-targeting antibody drug conjugate (#ADC) in select solid tumors including ovarian…
Liked by Brenda Wolling
-
So proud to be a part of #WMWorldAwarenessDay!
So proud to be a part of #WMWorldAwarenessDay!
Liked by Brenda Wolling
Experience & Education
-
Cellectar Biosciences, Inc.
View Brenda’s full experience
See their title, tenure and more.
or
Recommendations received
1 person has recommended Brenda
Join now to viewMore activity by Brenda
-
Cellectar Biosciences was excited to be a part of the first-ever Waldenstrom's Macroglobulinemia World Awareness Day yesterday and to support the…
Cellectar Biosciences was excited to be a part of the first-ever Waldenstrom's Macroglobulinemia World Awareness Day yesterday and to support the…
Liked by Brenda Wolling
-
I'm proud to announce that I've accepted a position in the Life Sciences Division of the Leidos Health Group as a Senior Program Manager. The…
I'm proud to announce that I've accepted a position in the Life Sciences Division of the Leidos Health Group as a Senior Program Manager. The…
Liked by Brenda Wolling
-
In addition to my one year anniversary at work, we're celebrating two years of having the coolest roof in the neighborhood. #joylandroofing
In addition to my one year anniversary at work, we're celebrating two years of having the coolest roof in the neighborhood. #joylandroofing
Liked by Brenda Wolling
-
Some of our great folks doing great work at #iuvoBioScience. Thanks to all of you, and Happy Employee Appreciation Day!
Some of our great folks doing great work at #iuvoBioScience. Thanks to all of you, and Happy Employee Appreciation Day!
Liked by Brenda Wolling
-
Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study https://bit.ly/42j0pSU…
Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study https://bit.ly/42j0pSU…
Liked by Brenda Wolling
-
Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data…
Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data…
Liked by Brenda Wolling
-
Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024, to Discuss Iopofosine I 131…
Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024, to Discuss Iopofosine I 131…
Liked by Brenda Wolling
-
Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s…
Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s…
Liked by Brenda Wolling
-
It’s been a wonderful and productive year. We all feel it. As the calendar makes another turn, what will happen over the next year? Change is the one…
It’s been a wonderful and productive year. We all feel it. As the calendar makes another turn, what will happen over the next year? Change is the one…
Liked by Brenda Wolling
-
Discover comprehensive resources and educational materials from leading organizations like the Multiple Myeloma Research Foundation - MMRF…
Discover comprehensive resources and educational materials from leading organizations like the Multiple Myeloma Research Foundation - MMRF…
Liked by Brenda Wolling
-
Post-treatment tests are done to ensure your treatment for #Waldenstromsmacroglobulinemia has worked correctly and to keep an eye on any potential…
Post-treatment tests are done to ensure your treatment for #Waldenstromsmacroglobulinemia has worked correctly and to keep an eye on any potential…
Liked by Brenda Wolling
-
Waldenstrom's Macroglobulinemia, a type of blood cancer affecting plasma cells, requires specialized care and support. Stay informed about the latest…
Waldenstrom's Macroglobulinemia, a type of blood cancer affecting plasma cells, requires specialized care and support. Stay informed about the latest…
Liked by Brenda Wolling
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Brenda Wolling
1 other named Brenda Wolling is on LinkedIn
See others named Brenda Wolling